Avalon GloboCare, founded with a mission to revolutionize biotechnology and healthcare services, focuses on developing diagnostic and therapeutic products. The company specializes in stem cell banking, oral cancer detection, and skin regeneration. Additionally, Avalon GloboCare has expanded its product line to include the KetoAir Breathalyzer, which monitors ketosis levels. Their market focus spans globally, serving clients worldwide with innovative healthcare solutions.
Notable figures affiliated with Avalon GloboCare include key investors and industry experts who have propelled the company's growth. The firm has achieved significant milestones, such as launching the KetoAir Breathalyzer in the U.S. and securing an exclusivity agreement for its distribution across multiple regions. Avalon GloboCare's impact is evident in its contributions to advancing medical diagnostics and therapeutic technologies, positioning itself as a leader in the biotech industry.
